EAHAD/LinkedIn
May 21, 2026, 07:23
EAHAD Highlights the Power of Clinical Trials in Haemophilia
EAHAD (European Association for Haemophilia and Allied Disorders) shared a post on LinkedIn:
“This Clinical Trials Day, we recognize the critical role that clinical research plays in driving innovation and improving outcomes for people living with haemophilia.
Within this context, the EAHAD Gene Therapy Trials Database provides a publicly accessible resource that consolidates the latest published gene therapy data, with a particular focus on safety outcomes.
By bringing structured and up-to-date evidence into one place, the platform supports a clearer understanding of ongoing and completed clinical research in the field.
Access the database.”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders